We are pleased to announce the launch of field trials of the beta version of our automated end-to-end AI solution for early detection of Diabetic Retinopathy. We are currently partnering with one of the largest tele-ophthalmology companies and conducting… Read More
Arun Shroff, CEO of Xtend.AI has taken on the role of a topic driver in the ITU/WHO Focus Group on AI for Health (FGAI4H) at the third meeting of the focus group in Lausanne, Switzerland in January, 2019. As a… Read More
Our proposal and solution on using “AI for Early Detection of Diabetic Retinopathy to Prevent Vision Loss” was presented to the ITU-WHO Focus Group on AI for Health at their second meeting held in New York city from Nov 14-16,… Read More
The second meeting of the ITU/WHO’s Focus Group on AI for Health (FG-AI4H) was held at Columbia University, New York, from Nov 14 -16, 2018. The aim of the workshop was to answer how artificial intelligence can be used to address global… Read More
The mathematical algorithm is based on deep machine learning, a type of artificial intelligence (AI) technology in which a neural network “learns” to perform a task through repetition and self-correction.
Retinal changes due to diabetic retinopathy may initially be symptomless. Diabetic retinopathy can be divided into two stages based on examination of retina. The stages are- Non-proliferative diabetic retinopathy – Small balloon-like swellings called microaneurysms develop in the blood… Read More
Arun Shroff was an invited expert and speaker at the second AI for Good Global Summit organized by the ITU in Geneva on 15-17 May 2018, in partnership with the XPRIZE Foundation, the Association for Computing Machinery (ACM) and sister United Nations agencies including UNESCO, UNICEF, WHO, and The… Read More
The AI and Global Health meeting was organized by Wilton Park, a not-for-profit executive agency of the Foreign and Commonwealth Office, U.K, from June 27 – 29, 2018. This Wilton Park meeting provided the opportunity for an exploration of Artificial… Read More